Inflammatory Bowel Disease (IBD) is on the rise, but many are unaware of its growing threat. The silent rise of IBD is a global concern, with Indonesia witnessing a steady increase in cases. Yet, the lack of public awareness is startling, as patients often overlook early symptoms, leading to delayed diagnoses and advanced disease stages.
Abdi Waluyo Hospital, in collaboration with the Asian Education Network in IBD (AENIBD) and the Indonesian Society of Gastroenterology (PGI), took a bold step forward with a scientific meeting in Jakarta. The event, 'Updates on Diagnosis and Management of Inflammatory Bowel Disease (IBD)', aimed to bridge the gap in early detection and clinical excellence.
IBD is a multifaceted condition, influenced by genetics, immunity, environmental factors, and gut microbiota. Crohn's disease and ulcerative colitis, its primary forms, often mimic symptoms of other conditions, making diagnosis challenging. But here's where it gets controversial—the intricate nature of IBD demands a meticulous diagnostic approach, combining clinical evaluations, endoscopy, histopathology, and more. And this is the part most people miss—a delayed diagnosis can have dire consequences.
Prof. dr. Marcellus Simadibrata, an internist at Abdi Waluyo Hospital, warns that late diagnoses and treatment initiation can significantly worsen the disease. This can lead to repeated hospitalizations and severe complications, including bleeding, intestinal blockages, fistulas, and an increased risk of colorectal cancer. The urgency of early intervention is undeniable.
Prof. Choon Jin Ooi, a renowned gastroenterologist, introduced AEN-IBD, a non-profit organization registered in Singapore, dedicated to uniting Asian experts in the field. He emphasized their commitment to advancing IBD knowledge, supporting professionals, fostering collaboration, and promoting excellence in care. The IBD Update 2026 is seen as a pivotal forum for knowledge exchange and network building among Asian clinicians.
PGI Chairman, Prof. Dr. dr. Ari Fahrial Syam, stressed the importance of medical collaboration in tackling IBD challenges. He highlighted the rapid global advancements in IBD science and therapy, urging the medical community to stay updated. By fostering scientific forums, clinicians can promote excellence in care, improve service quality, and enhance clinical outcomes for patients.
In Southeast Asia, IBD incidence is lower than in Western countries, but it's rising. Prof. Ari revealed regional studies showing incidence rates of 0.54 to 3.44 per 100,000 population, increasing with environmental and lifestyle changes. Indonesian referral hospitals also report a growing need for long-term IBD interventions.
Prof. Ari advocated for a comprehensive understanding of IBD as a complex disease with impaired immune tolerance, leading to chronic inflammation. He urged an integrated approach to diagnosis and management, considering both symptoms and underlying mechanisms.
Prof. Ling Khoon Lin, another distinguished gastroenterologist, discussed the shift in modern therapy for moderate to severe IBD. The focus is now on achieving comprehensive targets, including clinical remission, biochemical normalization, and mucosal healing. A treat-to-target strategy is vital to prevent disease progression and intestinal damage.
Furthermore, Prof. Ling emphasized the importance of screening for latent infections before administering advanced therapies. Evaluating tuberculosis, hepatitis B, and immunization status is crucial for patient safety and aligns with international clinical guidelines. He highlighted the need for personalized therapy, considering effectiveness, response speed, safety, and patient preferences.
Prof. Jose D. Sollano, Jr., brought attention to the pediatric aspect of IBD. He stressed that early symptoms in children are often overlooked, with recurrent abdominal pain being a key indicator. A family history of IBD significantly increases children's risk, and fistula-in-ano, a specific clinical condition, is frequently missed, leading to repeated surgeries. Early recognition in children is crucial to prevent long-term complications.
The IBD Update 2026 promises to empower participants with comprehensive knowledge for accurate diagnoses, tailored therapies, and effective long-term management. With this, physicians can deliver individualized and quality care to IBD patients, ultimately improving their lives. What are your thoughts on the rising IBD cases and the importance of early diagnosis? Share your insights and experiences in the comments below!
